New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
07:45 EDTISIS, FOLD, ABBV, PRXL, CEMP, ICLR, TSRO, BRLI, CSUUBS to hold a conference
2014 Global Healthcare Conference to be held in New York on May 19-21 with webcasted company presentations to begin on May 21 at 8 am; not all company presentations may be webcasted. Webcast Link
News For ISIS;TSRO;PRXL;CSU;ICLR;ABBV;BRLI;CEMP;FOLD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 26, 2015
12:02 EDTABBVEMA adopts positive opinion on AbbVie's Humira for acne inversa
Subscribe for More Information
June 25, 2015
16:04 EDTFOLDAmicus says EMA validates Galafold marketing authorization application
Subscribe for More Information
07:49 EDTPRXLPAREXEL shares should be bought on weakness, says Wells Fargo
Subscribe for More Information
June 24, 2015
07:26 EDTPRXLPAREXEL price target raised to $82 from $72 at UBS
UBS raised its price target on PAREXEL to $82 from $72 following the company's updated guidance. The firm sees gains from cost cutting, margin expansion and the growth of strategic partners. UBS reiterated its Buy rating on PAREXEL shares.
06:12 EDTABBVAbbVie announces new TURQUOISE-III study results
Subscribe for More Information
June 23, 2015
18:04 EDTISISIsis Pharma granted FDA orphan status for treatment of familial chylomicronemia
Subscribe for More Information
16:29 EDTCEMPOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
16:18 EDTPRXLPAREXEL maintains mid-point of prior FY15 EPS guidance at $2.74
Subscribe for More Information
16:17 EDTPRXLPAREXEL to record $35M-$45M charge from restructuring
Subscribe for More Information
16:13 EDTPRXLPAREXEL sees double digit growth in EPS for 2016
Subscribe for More Information
16:11 EDTPRXLPAREXEL sees FY16 EPS $3.02-$3.38, consensus $3.24
Sees FY16 revenue $2.16B-$2.21B, consensus $2.2B.
16:10 EDTPRXLPAREXEL narrows FY15 EPS view to $2.70-$2.78 from $2.65-$2.83, consensus $2.75
Subscribe for More Information
16:06 EDTPRXLPAREXEL sees Q4 EPS 70c-78c, consensus 75c
Subscribe for More Information
08:58 EDTISISIsis Pharmaceuticals shares not reflecting SMA data, says Needham
Subscribe for More Information
08:14 EDTCEMPCempra price target raised to $57 from $44 at Stifel
After meeting with Cempra's management, Stifel thinks the company has a number of near-term positive catalysts. The firm says that the stock's risk/reward appears to be positive heading into data on the company's solithromycin drug that is due to be released at the end of the year. Stifel keeps a Buy rating on the stock.
June 22, 2015
07:01 EDTISISIsis Pharmaceuticals reports data from ISIS-SMN Rx in Phase 2 study
Subscribe for More Information
June 21, 2015
14:16 EDTBRLIOPKO Health shares look pricey, Barron's says
Investors should steer clear of OPKO Health (OPK) and Bio-Reference Labs (BRLI) in light of their recent merger agreement, Barron's contends in a feature article. Though OPKO hopes to push its prostate cancer test, similar products have performed poorly on the market, and Barron's advises "only those who believe that [CEO and chairman Phillip Frost] can work miracles" to own the stock. Reference Link
June 19, 2015
15:53 EDTPRXLPAREXEL to host investor day
Subscribe for More Information
05:40 EDTTSROTESARO a favorite stock for second half of year at Mizuho
Subscribe for More Information
June 18, 2015
07:36 EDTABBVReceptos remains an attractive takeover candidate, says Leerink
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use